Therapeutic preparation for the transdermal administration of active substances
US6379696B1 · kind B1 · utility
11Cited by
5References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 5, 1998 |
| Grant date | Apr 30, 2002 |
| Priority date | — |
| Expiry date | May 5, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P17/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A therapeutic preparation for the transdermal application of active substances through the skin comprising additives causing an increase in the percutaneous absorption rate of active substances which can normally only insufficiently be absorbed transdermally is characterized by the fact that the additives are HMG-CoA-reductase-inhibitors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.